dc.rights.license | CC-BY-NC-ND | |
dc.contributor.advisor | Bernards, Rene | |
dc.contributor.author | Athanasopoulou, Niovi | |
dc.date.accessioned | 2024-10-26T00:01:44Z | |
dc.date.available | 2024-10-26T00:01:44Z | |
dc.date.issued | 2024 | |
dc.identifier.uri | https://studenttheses.uu.nl/handle/20.500.12932/48029 | |
dc.description.abstract | Cellular senescence, a response to various stress signals, involves a stable exit from the cell cycle
along with significant changes in cell function and physiology. Although many studies have
focused on senescence in non-cancerous cells, it is evident that cancer cells can also enter a
senescent state. Senescent cancer cells exhibit considerable variability due to both intrinsic and
extrinsic factors. In this review, we explore the heterogenous autonomous and non-cell
autonomous characteristics of senescent cancer cells and their diverse relationship to tumor
progression. In addition, we discuss the potential and challenges of using senotherapies as novel
anti-cancer treatments. By understanding the context-specific effects of senescent cancer cells,
we may be able to harness their tumor-suppressive benefits while minimizing their harmful
consequences, leading to new therapeutic strategies for cancer. | |
dc.description.sponsorship | Utrecht University | |
dc.language.iso | EN | |
dc.subject | In this review, we explore the heterogenous autonomous and non-cell
autonomous characteristics of senescent cancer cells and their diverse relationship to tumor
progression. In addition, we discuss the potential and challenges of using senotherapies as novel
anti-cancer treatments. | |
dc.title | Heterogeneity of senescence cancer cells and their pleiotropic non-cell autonomous effects | |
dc.type.content | Master Thesis | |
dc.rights.accessrights | Open Access | |
dc.subject.keywords | senescent cancer cells, heterogeneity, senotherapy | |
dc.subject.courseuu | Biology of Disease | |
dc.thesis.id | 40522 | |